肿瘤抑制因子
巨噬细胞
肺
化学
炎症
免疫学
生物
医学
白细胞介素6
生物化学
体外
内科学
作者
Daisy A. Hoagland,Patricia Rodríguez-Morales,Alexander O. Mann,Alan Y. Baez Vazquez,Shuang Yu,Alicia Lai,Harry Kane,Susanna M. Dang,Yunkang Lin,Louison Thorens,Shahinoor Begum,Martha A. Castro,Scott D. Pope,Jaechul Lim,Shun Li,Xian Zhang,Ming O. Li,Carla F. Kim,Ruaidhrí P. Jackson,Ruslan M. Medzhitov
出处
期刊:Science
[American Association for the Advancement of Science]
日期:2025-07-10
卷期号:389 (6756): 169-175
被引量:45
标识
DOI:10.1126/science.adi8828
摘要
Tissue repair programs must function alongside antiviral immunity to restore the lung epithelial barrier following infection. We found that macrophage-derived oncostatin M (OSM) counteracted the pathological effects of type I interferon (IFN-I) during infection and damage in mice. At baseline, OSM-deficient mice exhibited altered alveolar type II (ATII) epithelial cell states. In response to influenza or viral mimic challenge, mice lacking OSM exhibited heightened IFN-I responses and increased mortality. OSM delivery to the lung induced ATII proliferation and was sufficient to protect deficient mice against morbidity. Furthermore, OSM promoted organoid formation despite the growth-inhibitory effects of IFN-I. These findings identify OSM as an indispensable macrophage-derived growth factor that maintains the homeostasis of lung epithelial cells and promotes their proliferation to overcome IFN-I-mediated immunopathology.
科研通智能强力驱动
Strongly Powered by AbleSci AI